Adinoff, B. (1987) Hypothalamic-pituitary-adrenal axis function in recently abstinent alcoholics. In Alcohol Withdrawal and Noradrenergic Function (
Linnoila, M.). , 107, 875–889.
AL-Damluji, S., Perry, L., Tomlin, S., et al (1987) Alpha-adrenergic stimulation of corticotropin secretion by a specific central mechanism in man. Neuroendocrinology, 45, 68–76.
Allan, A. M. & Harris, R. A. (1987) Involvement of neuronal chloride channels in ethanol intoxication, tolerance and dependence. In Recent Developments in Alcoholism, Vol. 5 (ed. M. Galanter), pp. 313–325. New York: Plenum Press.
Alonso, G., Szafarczyk, A., Balmefrezol, M., et al (1986) Immunocytochemical evidence for stimulatory control by the ventral noradrenergic bundle of parvocellular neurons of the paraventricular nucleus secreting corticotropin releasing hormone and vasopressin in rats. Brain Research, 397, 297–307.
Anderson, W. W., Swartzwelder, H. S. & Wilson, W. A. (1987) The NMDA antagonist 2-amino-5-phosphonovalerate blocks stimulus train-induced epileptogenesis but not epileptiform bursting in the rat hippocampal slice. Journal of Neurophysiology, 57, 1–21.
Annunziato, L., Amoroso, S., Di Renzo, G., et al (1983) Increased GH responsiveness to dopamine receptor stimulation in alcohol addicts during the late withdrawal syndrome. Life Sciences, 33, 2651–2655.
Araneda, R. & Bustos, G. (1989) Modulation of dendritic release of dopamine by N-mcthyl-aspartate receptors in rat substantia nigra. Journal of Neurochemistry, 52, 962–970.
Ballenger, J. C. & Post, R. M. (1978) Kindling as a model for alcohol withdrawal syndromes. British Journal of Psychiatry, 133, 1–14.
Banna, N. R. (1969) Potentiation of cutaneous inhibition by ethanol. Experientia, 25, 619–620.
Bjorkqvist, S. E. (1975) Clonidine in alcohol withdrawal. Acta Psychiatrica Scandinavica, 52, 256–263.
Bone, G. H. A., Majchrowicz, E., Martin, P. R., et al (1989) A comparison of calcium antagonists and diazepam in reducing alcohol withdrawal tremors. Psychopharmacology, 99, 386–388.
Borg, S., Kvande, H. & Sedvall, G. (1981) Central norepinephrine metabolism during alcohol intoxication in addicts and healthy volunteers. Science, 213, 1135–1137.
Brown, M. E., Anton, R. F., Malcolm, R., et al (1988) Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis. Biological Psychiatry, 23, 507–514.
Brown, M. R., Fisher, L. A., Rivier, J., et al (1982) Corticotropin-releasing factor: effects on the sympathetic nervous system and oxygen consumption. Life Sciences, 30, 207–210.
Brunnino, J., Mumforo, J. P. & Keaney, F. P. (1986) Lofexidine in alcohol withdrawal states. Alcohol and Alcoholism, 21, 167–170.
Coffman, J. A. & Petty, F. (1985) Plasma GABA levels in chronic alcoholics. American Journal of Psychiatry, 142, 1204–1205.
Cole, B. J. & Koob, G. F. (1988) Propranolol antagonises the enhanced conditioned fear produced by corticotropin releasing factor. Journal of Pharmacology and Experimental Therapeutics, 247, 902–910.
Collinoridoe, G. L. & Bliss, T. V. P. (1987) NMDA receptors - their role in long-term potentiation. Trends in Neurological Science, 10, 288–293.
Cott, J. A., Carlsson, A., Engel, J., et al (1976) Suppression of ethanol-induced locomotor stimulation by GABA-like drugs. Naunyn-Schmiedeberg's Archives of Pharmacology, 295, 203–209.
Cowen, P. J. & Nutt, D. J. (1982) Abstinence syndromes after withdrawal of tranquilising drugs: a common neurochemical mechanism? Lancet, ii, 360–362.
Croucher, M. J., Collins, J. F. & Meldrum, B. S. (1982) Anticonvulsant action of excitatory amino acid antagonists. Science, 216, 899–901.
Daus, A. T., Freeman, W. M., Wilson, J., et al (1985) Clinical experience with 781 cases of alcoholism evaluated and treated on an inpatient basis by various methods. International Journal of Addiction, 20, 643–650.
Dave, J. R., Eiden, L. E., Karanian, J. W., et al (1986) Ethanol exposure decreases pituitary corticotropin-releasing factor binding, adenylate cyclase activity, proopiomelanocortin biosynthesis, and plasma beta-endorphin levels in the rat. Endocrinology, 118, 280–286.
Davidoff, R. S. (1973) Alcohol and presynaptic inhibition in isolated spinal cord preparation. Archives of Neurology, 28, 60–63.
Dolin, S. I. & Little, H. J. (1990) Calcium antagonists during ethanol administration. Journal of Pharmacology and Experimental Therapeutics
Dolin, S. I., Little, H. J., Hudspith, M., et al (1987) Increased dihydropyridine-sensitive calcium channels in rat brain may underlie ethanol physical dependence. Neuropharmacology, 26, 275–279.
Durand, D. & Carlen, P. L. (1984) Impairment of long-term potentiation in rat hippocampus following chronic ethanol treatment. Brain Research, 308, 325–332.
Ehlers, C. L. & Chaplin, R. I. (1987) Chronic ethanol exposure potentiates the locomotor-activating effects of corticotropin-releasing factor (CRF) in rats. Regulatory Peptides, 19, 345–353.
Ehlers, C. L., Henriksen, S., Wang, M., et al (1983) Corticotropin-releasing factor increases brain excitability and convulsive seizures in the rat. Brain Research, 278, 332–336.
Engel, J. & Liljeqvist, S. (1976) The effect of long-term ethanol treatment on the sensitivity of dopamine receptors in the nucleus accumbens. Psychopharmacology, 49, 253–257.
Fadda, F., Mosca, E., Meloni, R., et al (1985) Suppression by progabide of ethanol withdrawal syndrome in rats. European Journal of Pharmacology, 109, 321–325.
Feuerlein, W. & Reiser, E. (1986) Parameters affecting the course and results of delirium tremens treatment. Acta Psychiatrica Scandinavica (suppl. 329), 120–123.
Flink, E. B. (1986) Magnesium deficiency in alcoholism. Alcoholism: Clinical and Experimental Research, 10, 590–594.
Flink, E. B., McCollister, R., Prasad, A. S., et al (1957) Evidence for clinical magnesium deficiency. Annals of Internal Medicine, 47, 956–968.
Franklin, C. L. & Gruol, D. L. (1987) Acute ethanol alters the firing pattern and glutamate response of cerebellar Purkinje neurons in culture. Brain Research, 416, 205–218.
Freund, G. (1980) Benzodiazepine receptor loss in brains of mice after chronic alcohol consumption. Life Sciences, 27, 987–992.
Frye, G. D. & Breese, G. R. (1982) GABAergic modulation of ethanol-induced motor impairment. Journal of Pharmacology and Experimental Therapeutics, 223, 750–756.
Gallimberti, L., Canton, G., Gentile, N., et al (1989) Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet, ii, 787–789.
Garthwaite, G. & Garthwaite, J. (1986) Amino acid toxicity: intracellular sites of calcium accumulation associated with the onset of irreversible damage to rat cerebellar neurones in vitro. Neuroscience Letters, 71, 53–58.
Glue, P. & Nutt, D. J. (1987) Clonidine in alcohol withdrawal: a pilot study of differential symptom responses following i.v. clonidine. Alcohol and Alcoholism, 22, 161–166.
Glue, P., Sellman, J. D., Nicholl, M. G., et al (1989) Studies of alpha-2–adrenoceptor function in abstinent alcoholics. British Journal of Addiction, 84, 97–102.
Golbert, T. M., Sanz, C. J., Rose, H. D., et al (1967) Comparative evaluation of treatments of alcohol withdrawal syndromes. Journal of the American Medical Association, 201, 113–116.
Hawley, R. J., Major, L. F., Schulman, E., et al (1981) Cerebrospinal fluid cyclic nucleotides and GABA do not change in alcohol withdrawal. Life Sciences, 28, 295–299.
Hawley, R. J., Major, L. F., Schulman, E., et al (1985) Cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol and norepinephrine levels in alcohol withdrawal. Archives of General Psychiatry, 42, 1056–1062.
Heaton, F. W., Pyrah, L. N., Beresford, C. C., et al (1962) Hypomagnesaemia in chronic alcoholism. Lancet, ii, 802–805.
Herron, C. E., Lester, R. A. J., Coan, E. J., et al (1985a) Intracellular demonstration of an N-methyl-D-aspartate receptor mediated component of synaptic transmission in the rat hippocampus. Neuroscience Letters, 60, 19–23.
Herron, C. E., Williamson, R. & Collingridge, G. L. (1985b) A selective N-methyl-D-aspartate antagonist depresses epileptiform activity in rat hippocampal slices. Neuroscience Letters, 61, 255–260.
Heuser, I., Von Bardeleben, U., Boll, E., et al (1988) Response of ACTH and Cortisol to human corticotropin-releasing hormone after short-term abstention from alcohol abuse. Biological Psychiatry, 24, 316–321.
Hoffman, P. L., Moses, F., Hudspith, M., et al (1989a) Ethanol: potent and selective inhibitor of NMDA-stimulated cyclic GMP production. Research Society on Alcohol Abstracts, Colorado, 312 ().
Hoffman, P. L., Rabe, C. S., Moses, F., et al (1989b) N-methyl-D-aspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production. Journal of Neurochemistry, 52, 1937–1940.
Holsboer, F., Von Bardeleben, U., Buller, R., et al (1987) Stimulation response to corticotropin-releasing hormone (CRH) in patients with depression, alcoholism and panic disorder. Hormonal and Metabolic Research (suppl. 16), 80–88.
Holzbach, E. & Buhler, K. E. (1978) Die behandlung des delirium tremens mit haldol. Nervenartz, 49, 405–409.
Jones, S. M., Snell, L. D. & Johnson, K. M. (1987) Phencyclidinc selectively inhibits N-methyl-D-aspartate-induced hippocampal (3H)norepinephrine release. Journal of Pharmacology and Experimental Therapeutics, 240, 492–497.
Kaim, S. C., Klett, C. J. & Rothfield, B. (1969) Treatment of the acute alcohol withdrawal syndrome: a comparison of four drugs. American Journal of Psychiatry, 125, 1640–1646.
Kanzow, W. T. (1986) The clinical stages of alcoholic delirium and their therapeutic significance. Acta Psychiatrica Scandinavica (suppl. 329), 124–128.
Kitazawa, S., Shioda, S. & Nakai, Y. (1987) Catecholaminergic innervation of neurons containing corticotropin-releasing factor in the paraventricular nucleus of the rat hypothalamus. Acta Anatomica, 129, 337–343.
Kobinger, W. (1984) Alpha-2–adrenoceptors in cardiovascular regulation of norepinephrine. In Frontiers of Clinical Science, Vol. 2 (eds M. G. Ziegler & C. R. Lake), pp. 307–326. Baltimore: Williams and Wilkins.
Koob, G. F. & Bloom, F. E. (1985) Corticotropin-releasing factor and behaviour. Federation Proceedings, 44, 259–263.
Koppi, S., Eberhardt, G., Haller, R., et al (1987) Calcium channel blocking agent in the treatment of acute alcohol withdrawal – caroverine versus meprobamate in a randomised double blind study. Neuropsychobiology, 17, 49–52.
Kramp, P., Ronsted, P. & Hansen, T. (1979) Barbital and diazepam plasma levels during treatment of delirium tremens. Acta Psychiatrica Scandinavica, 59, 263–275.
Krystal, H. (1959) The physiological basis of the treatment of delirium tremens. American Journal of Psychiatry, 116, 137–147.
Lalies, M., Middlemiss, D. N. & Ransom, R. (1988) Stereoselective antagonism of NMDA-stimulated noradrenaline release from rat hippocampal slices by MK-801. Neuroscience Letters, 91, 339–342.
Liljeqvist, S. (1978) Changes in the sensitivity of dopamine receptors in the nucleus accumbens and in the striatum induced by chronic ethanol administration. Acta Pharmacologica et Toxicologica, 43, 19–28.
Liljeqvist, S. & Engel, J. (1982) Effects of GABAergic agonists and antagonists on various ethanol-induced behavioural changes. Psychopharmacology, 78, 71–75.
Linnoila, M. (1987) Alcohol withdrawal and noradrenergic function. Annals of Internal Medicine, 107, 875–889.
Lishman, W. A. (1987) Brain damage in alcoholism: current concepts. Acta Medica Scandinavica (suppl. 717), 5–17.
Lister, R. G. & Karanian, J. W. (1987) RO 15–4513 induces seizures in DBA/2 mice undergoing alcohol withdrawal. Alcohol, 4, 409–411.
Lister, R. G. & Nutt, D. J. (1987) Is RO 15–4513 a specific alcohol antagonist? Trends in Neurological Science, 10, 223–225.
Little, H. J., Dolin, S. J. & Halsey, M. J. (1986) Calcium channel antagonists decrease the ethanol withdrawal syndrome in rats. Life Sciences, 39, 2059–2065.
Littleton, J. (1989) Alcohol intoxication and physical dependence: a molecular mystery tour. British Journal of Addiction, 84, 267–276.
Littleton, J. & Little, H. J. (1988) Dihydropyridine-sensitive Ca channels in brain are involved in the central nervous system hyper-excitability associated with alcohol withdrawal states. Annals of the New York Academy of Science, 552, 199–202.
Lovinger, D. M., White, G. & Weight, F. F. (1989) Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science, 243, 1721–1724.
Lynch, M. A. & Littleton, J. M. (1983) Possible association of alcohol tolerance with increased synaptic Ca sensitivity. Nature, 303, 175–177.
Marley, R. J. & Wehner, J. M. (1987) GABA enhancement of flunitrazepam binding in mice selectively bred for differential sensitivity to ethanol. Alcohol and Drug Research, 7, 25–32.
Martz, A., Deitrich, R. A. & Harris, R. A. (1983) Behavioural evidence for the involvement of gamma-aminobutyric acid in the actions of ethanol. European Journal of Pharmacology, 89, 53–62.
Meldrum, B., Anelzark, G. & Trimble, M. (1975) Drugs modifying dopaminergic activity and behaviour, the EEG, and epilepsy in papio papio
. European Journal of Pharmacology, 32, 203–213.
McNamara, J. O., Russell, R. D., Rigsbee, L., et al (1988) Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models. Neuropharmacology, 27, 563–568.
Nesteros, J. M. (1980) Ethanol specifically potentiates GABA-mediated neurotransmission in feline cerebral cortex. Science, 209, 708–710.
Nowak, L., Bregestovski, P., Ascher, P., et at (1984) Magnesium gates glutamate-activated channels in mouse central neurones. Nature, 307, 462–465.
Nutt, D. J. & Glue, P. (1986) Monoamines and alcohol. British Journal of Addiction, 81, 327–338.
Nutt, D. J., Adinoff, B., Ravitz, B., et al (1988a) Cerebrospinal fluid studies in alcoholics and violent offenders. Australian Drug and Alcohol Review, 7, 105–108.
Nutt, D. J., Glue, P., Molyneux, S., et al (1988b) Alpha-2-adrenoceptor activity in alcohol withdrawal: a pilot study of the effects of i.v. clonidine in alcoholics and normals. Alcoholism: Clinical and Experimental Research, 12, 14–18.
Olney, J. W. (1984) Excitotoxins: an overview. In Excitotoxins (eds K. Fuxe, P. J. Roberts & R. Schwarcz), p. 82–96. London: Macmillan.
Palsson, A. (1986) The efficacy of early chlormethiazole medication in the prevention of delirium tremens. A retrospective study of the outcome of different treatment strategies at the Helsingborg psychiatric clinics, 1975–1980. Acta Psychiatrica Scandinavica (suppl. 329), 140–145.
Potter, J. F., Bannan, L. T. & Beevers, D. G. (1984) The effect of a non-selective lipophilic beta-blocker on the blood pressure and noradrenaline, vasopressin, Cortisol and renin release during alcohol withdrawal. Clinical Experiments in Hypertension - Theory and Practice, A6, 1147–1160.
Racine, R. J., Milgram, N. W. & Hafner, S. (1983) Long-term potentiation phenomena in the rat limbic forebrain. Brain Research, 260, 217–231.
Rastogi, S. K., Thyagarajan, R., Clothier, J., et al (1986) The effect of chronic treatment of ethanol on benzodiazepine and picrotoxin sites on the GABA-receptor complex in regions of the brain of the rat. Neuropharmacology, 25, 1179–1184.
Risher-Flowers, D., Adinoff, B., Ravitz, B., et al (1988) Circadian rhythms of Cortisol during alcohol withdrawal. Advances in Alcohol and Substance Abuse, 7, 37–41.
Rivier, C., Bruhn, T. & Vale, W. (1984) Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF). Journal of Pharmacology and Experimental Therapeutics, 229, 127–131.
Robinson, B. J., Robinson, G. M., Maling, T. J. B., et al (1989) Is clonidine useful in the treatment of alcohol withdrawal? Alcoholism: Clinical and Experimental Research, 13, 95–98.
Rottenberg, H. (1985) Alcohol modulation of benzodiazepine receptors. Alcohol, 2, 203–207.
Sapolsky, R. M. & Pulsinelli, W. A. (1985) Glucocorticoids potentiate ischaemic injury to neurons: therapeutic implications. Science, 229, 1397–1400.
Seilicovich, A., Duvilanski, B., Gonzales, N. N., et al (1985) The effect of acute ethanol administration on GABA receptor binding in cerebellum and hypothalamus. European Journal of Pharmacology, 111, 365–369.
Sellers, E. M., Naranjo, C. A., Harrison, M., et al (1983) Diazepam loading: simplified treatment of alcohol withdrawal. Clinical Pharmacology and Therapeutics, 34, 822–826.
Schwarcz, R. & Meldrum, B. (1985) Excitatory aminoacid antagonists provide a therapeutic approach to neurological disorders. Lancet, ii, 140–143.
Schwarcz, R., Collins, J. F. & Parks, D. A. (1982) α-Amino-phosphonocarboxylates block ibotenate but not kainate neurotoxicity in rat hippocampus. Neuroscience Letters, 33, 85–90.
Slater, N. T., Stelzer, A. & Galvan, M. (1985) Kindling-like stimulus patterns induce epileptiform discharges in the guinea pig in vitro hippocampus. Neuroscience Letters, 60, 25–31.
Snyder, S. H. (1980) Phencyclidine. Nature, 285, 355–356.
Stelzer, A., Slater, N. T. & Bruggencate, G. (1987) Activation of NMDA receptors blocks GABAergic inhibition in an in vitro model of epilepsy. Nature, 326, 698–701.
Suzdak, P. D., Schwartz, R. D., Skolnick, P., et al (1986a) Ethanol stimulates gamma-aminobutyric acid receptor-mediated chloride transport in rat brain synaptoneurosomes. Proceedings of the National Academy of Sciences, 83, 4071–4075.
Suzdak, P. D., Glowa, J. R., Crawley, J. N., et al (1986b) A selective imidazobenzodiazepine antagonist of ethanol in the rat. Science, 234, 1243–1247.
Swanson, L. W. (1976) The locus coeruleus: a cytoarchitectonic, golgi and immunohistochemical study in the albino rat. Brain Research, 110, 39–56.
Taylor, K. M. & Laverty, R. (1969) The effect of chlordiazepoxide, diazepam and nitrazepam on catecholamine metabolism in regions of the rat brain. European Journal of Pharmacology, 8, 296–301.
Thomas, D. W. & Freedman, D. X. (1964) Treatment of the alcohol withdrawal syndrome. Journal of the American Medical Association, 188, 316–318.
Thompson, W. L., Johnson, A. D. & Maddrey, W. L. (1975) Diazepam and paraldehyde for treatment of severe delirium tremens. Annals of Internal Medicine, 82, 175–180.
Ticku, M. K. & Davis, W. C. (1981) Evidence that ethanol and pentobarbital enhance 3H-diazepam binding at the benzodiazepine-GABA receptor-ionophore complex indirectly. European Journal of Pharmacology, 71, 521–522.
Ticku, M. K. & Rastogi, S. K. (1986) Barbiturate-sensitive sites on the benzodiazepine-GABA receptor-ionophore complex. In Molecular and Cellular Mechanisms of Anaesthetics (eds S. H. Roth & K. W. Miller), pp. 178–188. New York: Plenum Press.
Ticku, M. K., Burch, T. P. & Davis, W. C. (1983) The interactions of ethanol with the benzodiazepine-GABA receptor-ionophore complex. Pharmacology Biochemistry and Behaviour, 18, 15–18.
Ticku, M. K., Lowrimore, P. & Lehoullier, P. (1986) Ethanol enhances GABA-induced 36-C1-influx in primary spinal cord cultured neurons. Brain Research Bulletin, 17, 123–126.
Tran, V. T., Snyder, S. H., Major, L. F., et al (1981) GABA receptors are increased in the brains of alcoholics. Annals of Neurology, 9, 289–292.
Vale, W., Speiss, J., Rivier, C., et al (1981) Characterization of a 41–residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science, 213, 1394–1397.
Valentino, R. J., Foote, S. L. & Aston-Jones, G. (1983) Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Research, 270, 363–367.
Valimaki, M., Pelkonen, R., Harkonen, M., et al (1984) Hormonal changes in noncirrhotic male alcoholics during ethanol withdrawal. Alcohol and Alcoholism, 19, 235–242.
Vezzani, A., Wu, H-Q., Montena, E., et al (1988) Role of the N-methyl-D-aspartate-type receptors in the development and maintenance of hippocampal kindling in rats. Neuroscience Letters, 87, 63–68.
Victor, M. (1966) Treatment of alcoholic intoxication and the withdrawal syndrome. Psychosomatic Medicine, 28, 636–650.
Victor, M. & Adams, R. D. (1953) The effects of alcohol on the nervous system. Research Publications of the Association for Nervous and Mental Diseases, 32, 526–573.
Walinder, J., Balldin, J., Bokstrom, K., et al (1981) Clonidine suppression of the alcohol withdrawal syndrome. Drug and Alcohol Dependence, 8, 345–348.
Walker, D. W., Barnes, D. E., Zornetzer, S. F., et al (1980) Neuronal loss in hippocampus induced by prolonged ethanol consumption in rats. Science, 209, 711–713.
Watkins, J. C. & Evans, R. H. (1981) Excitatory amino acid transmitters. Annual Reviews in Pharmacology and Toxicology, 21, 165–204.
Weiss, S. R. B., Post, R. M., Gold, P. W., et al (1986) CRF-induced seizures and behaviour: interaction with amygdala kindling. Brain Research, 372, 345–351.
Whittington, M. A. & Little, H. J. (1988) Nitrendipine prevents the ethanol withdrawal syndrome when administered chronically with ethanol prior to withdrawal. British Journal of Pharmacology, 94, 385.
Whyte, K. F., Addis, G. J., Whitesmith, R., et al (1987) Adrenergic control of plasma magnesium in man. Clinical Science, 72, 135–138.
Wilkins, A. J., Jenkins, W. J. & Steiner, J. A. (1983) Efficacy of clonidine in the treatment of the alcohol withdrawal syndrome. Psychopharmacology, 81, 78–80.
Wolfe, S. M. & Victor, M. (1969) The relationship of hypomagnesaemia and alkalosis to alcohol withdrawal symptoms. Annals of the New York Academy of Science, 162, 973–984.